Enanta Pharmaceuticals Inc (NASDAQ:ENTA)
| 64.68 Delayed Data As of 4:00pm ET |  +0.96 / +1.51%Today’s Change | 57.15 Today|||52-Week Range 106.80 | -8.68% Year-to-Date |
Latest ENTA News | Press Releases
No recent news for Enanta Pharmaceuticals Inc.
Today’s Trading
| Previous close | 63.72 |
| Today’s open | 63.73 |
| Day’s range | 63.43 - 64.88 |
| Volume | 156,857 |
| Average volume (3 months) | 198,236 |
| Market cap | $1.3B |
Data as of 4:00pm ET, 12/10/2019
Growth & Valuation
| Earnings growth (last year) | -36.62% |
| Earnings growth (this year) | -136.32% |
| Earnings growth (next 5 years) | -83.30% |
| Revenue growth (last year) | -0.69% |
| P/E ratio | 29.3 |
| Price/Sales | 6.14 |
| Price/Book | 2.73 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| FTSVForty Seven Inc | +4.23 | +13.88% |
| ATNXAthenex Inc | +0.84 | +5.07% |
| CNSTConstellation Pharma... | -0.63 | -1.74% |
| YMABY-mAbs Therapeutics,... | +0.89 | +2.71% |
Data as of 4:00pm ET, 12/10/2019
Financials
| Next reporting date | February 6, 2020 |
| EPS forecast (this quarter) | $0.63 |
| Annual revenue (last year) | $205.2M |
| Annual profit (last year) | $46.4M |
| Net profit margin | 22.60% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Watertown, Massachusetts |
Forecasts
